Print Page

藥 物 回 收

 
The United Kingdom: Class 2 Medicines Recall: Pfizer Limited, Accuretic 10/12.5 mg film-coated tablets (English only)
 
Medicines and Healthcare products Regulatory Agency (MHRA) announces that Pfizer Limited is voluntarily recalling Accuretic 10/12.5 mg film-coated tablets (quinapril hydrochloride/hydrochlorothiazide) (batch number: DD4842) as a precautionary measure due to the identification of a nitrosamine above the acceptable limit. Following testing, N-nitroso-quinapril, has been observed at a level above the acceptable limit. Nitrosamines may increase the risk of cancer if people are exposed to them above acceptable levels and over long periods of time. The recall is at pharmacy and wholesaler level.

Please refer to the following website in MHRA for details: http://www.gov.uk/drug-device-alerts/class-2-medicines-recall-pfizer-limited-accuretic-10-slash-12-dot-5-mg-film-coated-tablets-el-22-a-slash-16

In Hong Kong, the above product is not a registered pharmaceutical product. Related news was previously issued by Health Canada and the United States Food and Drug Administration, and was posted on the Drug Office website on 4 Mar 2022 and 23 Mar 2022.

Ends/Tuesday, Mar 29, 2022
Issued at HKT 14:00
 
Related Information:
The United States: Lupin Pharmaceuticals, Inc. issues voluntary nationwide recal... 上載於 2022-12-22
Australia: Quinapril blood pressure medicines: Safety advisory – low levels of c... 上載於 2022-12-09
The United States: Aurobindo Pharma USA, Inc. Initiates Voluntary Nationwide Rec... 上載於 2022-10-26
Australia: Quinapril: Low levels of contamination with N-nitroso-quinapril (Engl... 上載於 2022-08-18
The United States: Pfizer voluntary nationwide recall of lots of Accuretic (quin... 上載於 2022-03-23
Canada: Pfizer recalls Accuretic blood pressure tablets due to a nitrosamine imp... 上載於 2022-03-04
 
back